Friday 6 November 2026 Export UFPT’s income statement to Excel — free account

UFP Technologies, Inc.

UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024.

Revenue: +11.6%
EPS: +25.6%
Free cash flow: −35.8%
Total debt: −40.2%

Quarter to September 2026, against a year earlier

301.69 1.87 +0.62%

Follow UFPT

Alert me

Market cap: $2.3B
P/E: 30.1×
Fwd P/E: 29.2×
Dividend yield: —
F-score: 5/9
Altman Z: 6.86
Beneish M: −2.57
Dividend safety: n/a

Overview

UFP Technologies, Inc. (UFPT) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, UFP Technologies, Inc. (UFPT) trades at a price to free cash flow of 37.5×. Over the past ten years it has ranged from 0.0× (December 2022) to 388× (June 2022); the current reading is higher than 71% of that period. That is above the Medical Devices industry median of 28.8× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/UFPT/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="UFP Technologies, Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/UFPT/metrics/price-to-free-cash-flow">UFP Technologies, Inc. (UFPT) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	21.6×	(37.95%)
FY2024	34.9×	(14.90%)
FY2023	41.0×	(49.92%)
FY2022	81.9×	39.54%
FY2021	58.7×	249.44%
FY2020	16.8×	16.02%
FY2019	14.5×	4.69%
FY2018	13.8×	(50.90%)
FY2017	28.1×	(67.86%)
FY2016	87.6×	—

Period	Price to free cash flow	Change
Sep 2026	37.4×	12.04%
Jun 2026	33.4×	55.26%
Mar 2026	21.5×	(0.72%)
Dec 2025	21.6×	23.01%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 388×

Ten-year median 24.2×

Current reading's percentile 71

Company	Price to free cash flow
BFLY Butterfly Network, Inc. compare	n/m
ESTA Establishment Labs Holdings Inc. compare	n/m
NVCR NovoCure Limited compare	n/m
ALMR Alamar Biosciences, Inc. compare	n/m
INSP Inspire Medical Systems, Inc. compare	19.6×
UFPT UFP Technologies, Inc.	37.5×
NEOG Neogen Corporation compare	51.0×
TMDX TransMedics Group, Inc. compare	53.5×
AXGN AxoGen, Inc. compare	134×
Medical Devices industry median	28.8×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

UFP Technologies, Inc. (UFPT) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on UFPT

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on UFPT

Stockrow Weekly